Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Clinical Proton MR Spectroscopy in Central Nervous System Disorders.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Remyelination: The True Regeneration of the Central Nervous System.
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Recombinant Expression of Margatoxin and Agitoxin-2 in Pichia pastoris: An Efficient Method for Production of K(V)1.3 Channel Blockers.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Fulminant demyelinating diseases.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
[Emerging therapies for multiple sclerosis.]
Dimethyl fumarate - only an anti-psoriatic medication?
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
[New therapies in multiple sclerosis].
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.

Pages